Latest Investment News

BPH Energy has raised $1.2 million through a share placement to accelerate its hydrocarbon projects and support Cortical Dynamics, ahead of a critical Federal Court hearing on its PEP-11 permit extension.

High-Tech Metals Ltd’s latest drilling at the Wagtail gold deposit delivers exceptional high-grade results, including a standout 1m intercept grading 171.35 g/t Au, reinforcing the deposit’s production potential. Ongoing drilling and development studies signal momentum towards near-term mining.

Findi Limited has resumed trading on the ASX following a key announcement about a strategic investment secured by its Indian subsidiary, signaling renewed investor interest.

Findi Limited’s Indian arm has locked in a A$72 million strategic investment from Nova Global, setting the stage for rapid growth in ATM deployments and digital payments. Alongside this, the company has refreshed its board with seasoned financial services experts to steer its next phase.

Osmond Resources has raised A$6.6 million through a discounted placement to fund its 2026 work program targeting titanium, zircon, and rare earth extraction in Spain. The capital boost positions the company to progress its Orión EU Critical Minerals Project amid growing EU demand for local supply.

Venari Minerals has received final drill assay results from its Red Mountain Lithium Project in Nevada, setting the stage for a maiden Mineral Resource Estimate amid a strong lithium market rebound.

Electro Optic Systems (EOS) has acquired European defence tech firm MARSS, integrating advanced AI-enabled command and control systems to create a comprehensive counter-drone solution. This strategic move positions EOS as a prime contractor for larger defence programs and expands its global footprint.

Eden Innovations has secured a $2.2 million strategic investment to fully repay its remaining iBorrow debt, eliminating costly interest payments and strengthening its balance sheet ahead of anticipated revenue growth.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.

Super Retail Group has reported a record 13.1% sales growth in the first half of FY26, with normalised profit before tax expected between $172 million and $175 million despite margin challenges and weather impacts.

Regal Partners anticipates a strong 2025 with normalised NPAT reaching $145 million, propelled by a significant jump in performance fees and funds under management climbing to $20.8 billion.

EBR Systems reported a doubling of WiSE System implants in Q4 FY2025 alongside the launch of key clinical studies and preliminary revenue guidance, signalling strong commercial and clinical momentum.